IRLAB Therapeutics AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 05/06/2026 BST			5-day change	1st Jan Change
1.268 ^SEK	+0.32%		+3.76%	-35.63%

06-05	IRLAB Therapeutics AB Announces Board Elections, Effective June 5, 2026	CI
06-05	Irlab rights issue now 91 percent secured	FW

Published on 05/10/2023 at 09:00 am BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Welcome. Research company IRLAB have released its report for the first quarter in 2023. To present the results, I have on link CEO, Gunnar Olsson;

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

06-05	IRLAB Therapeutics AB Announces Board Elections, Effective June 5, 2026	CI
06-05	Irlab rights issue now 91 percent secured	FW
05-06	IRLAB Q1 operating result swings to profit of SEK 10.7 mln	RE
05-06	Irlab reports growth in revenue and operating profit	FW
05-06	IRLAB Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Verisure climbs on earnings, OMXS30 index gains 1.2 percent	FW
05-05	Eight stocks hit new 52-week lows on the Stockholm Stock Exchange so far today	FW
05-05	Irlab launches SEK 68 million rights issue	FW
05-05	Irlab resolves on rights issue, obtains extended loan financing	RE
04-17	Christer Nordstedt Declines Re-Election as Board Member of IRLAB Therapeutics AB	CI
04-17	Irlab proposes two new board members; Chair to step down this autumn	FW
03-17	Irlab to present pirepemat data and AI platform at AD/PD conference	FW
03-04	Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc	FW
02-26	Study progress triggers $3 mln payment for IRLAB	RE
02-26	Stockholm Stock Exchange Rises for Third Consecutive Day, OMXS30 Index Up 0.3 Percent	FW